Mirati Therapeutics Inc
MRTX
Market Cap$4.12B
Close$
$66.66
13.6% upside
Current Fair Value
13.6% upsideUndervalued by 13.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.12 Billion |
|---|---|
| Enterprise Value | $3.90 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-13.18 |
| Beta | 0.77 |
| Outstanding Shares | 64,993,079 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.26 |
|---|---|
| PEG | 167.65 |
| Price to Sales | - |
| Price to Book Ratio | 4.19 |
| Enterprise Value to Revenue | 102.15 |
| Enterprise Value to EBIT | -5.09 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Mirati Therapeutics Inc
CEO: Charles Baum